about
Role of bacteria in oncogenesisProspective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health StudyPlasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective studyProstate cancer and inflammation: the evidence.Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control studyProstate myths: What is the prostate awareness in the general male population in Turkey?Sexually transmissible infections and prostate cancer riskSexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses.Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.False-positive prostate cancer markers in a man with symptomatic urethral Chlamydia trachomatis infection.Ocular clinical pictures disclosed by PCR molecular diagnosis of Chlamydia trachomatis infection performed following the appropriate sampling modality in ocular ecosystem.Inflammation and prostate carcinogenesis.Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.The inflammatory microenvironment and microbiome in prostate cancer development.A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0.-ΔG is associated with prostate cancer among men at increased risk of sexually transmitted infections
P2860
Q24633180-941B7FEB-AEA3-488C-8B6B-8FE9474AF3D9Q24650442-DD1F92AA-9BD2-4B7E-B2B9-5505C0BAB102Q28219236-334026DA-8F37-48AD-9C95-9ED5F59209B2Q33642321-8D7A6D58-4AC0-4767-ABFF-F010801851D5Q33811238-86B01346-8A74-42F3-BF93-29CB6055B04CQ35993273-A1FA7F30-F28B-43EF-A9D0-8CE793A52648Q36920062-C7D7BD91-989B-472B-9F0B-4AA7C0A26255Q37783620-E0B87012-A640-4AD3-8F71-04602EEF8A00Q37837451-8C8E3075-1478-4BA5-ABE4-277F2363B36DQ37845965-BD57077A-EFD7-4F61-A449-085C49974F32Q37847322-D1B72709-7D36-4E7C-8535-3390C61C4B38Q38031257-7171C32C-B21C-40B2-81AC-B15EFD1B4355Q38397934-13389FCB-7DFF-46C4-AC07-2AA8FF29DE39Q46271291-870F4112-10EA-44AF-A3C5-13B013B6C53CQ52591825-47EE20E3-7F1F-4101-99E6-45EB3B0729E5Q59136722-F319998C-20FD-4348-98AB-BAE06F2EC4F7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chlamydial antibodies and risk of prostate cancer.
@en
Chlamydial antibodies and risk of prostate cancer.
@nl
type
label
Chlamydial antibodies and risk of prostate cancer.
@en
Chlamydial antibodies and risk of prostate cancer.
@nl
prefLabel
Chlamydial antibodies and risk of prostate cancer.
@en
Chlamydial antibodies and risk of prostate cancer.
@nl
P2093
P1476
Chlamydial antibodies and risk of prostate cancer.
@en
P2093
Leena Tenkanen
Maija Leinonen
Matti Hakama
Matti Lehtinen
Pekka Saikku
Pär Stattin
Randi Elin Gislefoss
Sonja Lumme
Steinar Thoresen
Tapio Luostarinen
P304
P356
10.1158/1055-9965.EPI-03-0325
P577
2005-02-01T00:00:00Z